“Therefore, we evaluated cost-effectiveness and impact of a more targeted approach, vaccinating persons aged 60 years or older in states and counties with consistently elevated disease incidence, with the goal of guiding future vaccine development and ...
from Google Alert - health https://ift.tt/3daPx11
via IFTTT
0 comments:
Post a Comment